Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Exosomes and MicroRNAs in Biomedical Science — Hamed Mirzaei (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Exosomes and MicroRNAs in Biomedical Science
Shared by
Michael R Hamblin
Exosomes and MicroRNAs in Biomedical Science
Book
2022
en
Authors
+2 more
HM
Hamed Mirzaei
NR
Neda Rahimian
HM
Hamid Reza Mirzaei
Related publications
Article
2022
Exosomes and MicroRNAs in Biomedical Science
Hamed Mirzaei
,
Neda Rahimian
,
Hamid Reza Mirzaei
,
Javid Sadri Nahand
,
Michael R Hamblin
Article
2019
MicroRNAs and exosomes: key players in HIV pathogenesis
Javid Sadri Nahand
,
Farah Bokharaei‐Salim
,
Mohammad Reza Karimzadeh
,
Mohsen Moghoofei
,
Sajad Karampoor
,
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
HR Mirzaei
,
Alireza Tabibzadeh
,
Amir Jafari
,
Amir Ghaderi
,
Zatollah Asemi
,
Hamed Mirzaei
,
Michael R Hamblin
Article
2020
Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis
A Ghaemmaghami
,
Maryam Mahjoubin‐Tehran
,
Ahmad Movahedpour
,
Korosh Morshedi
,
Amirhossein Sheida
,
Seyed Pouya Taghavi
,
Hamed Mirzaei
,
Michael R Hamblin
Article
2022
Microfluidics for detection of exosomes and microRNAs in cancer: State of the art
Seyed Mojtaba Mousavi
,
Seyed Mohammad Amin Mahdian
,
Mohammad Saeid Ebrahimi
,
Mohammad Taghizadieh
,
Massoud Vosough
,
Javid Sadri Nahand
,
Saereh Hosseindoost
,
Nasim Vousooghi
,
Hamid Akbari Javar
,
Bagher Larijani
,
Mahmoudreza Hadjighassem
,
Neda Rahimian
,
Michael R Hamblin
,
Hamed Mirzaei
Article
2019
Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A review
Javid Sadri Nahand
,
Mohsen Moghoofei
,
Arash Salmaninejad
,
Zahra Bahmanpour
,
Mohammad Reza Karimzadeh
,
Mitra Nasiri
,
Hamid Reza Mirzaei
,
Hamid Reza Mirzaei
,
Mohammad Hossein Pourhanifeh
,
Farah Bokharaei‐Salim
,
Hamed Mirzaei
,
Hamed Mirzaei
,
Michael R Hamblin
Discussion(0)
No comments yet. Be the first to comment.